Summary : AstraZeneca (AZ) has reported preliminary data from a trial it conducted on its COVID-19 booster shot, Vaxzevria. The results from…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Category:
Companies
-
-
AbbVieCompaniesGlobal Market
VUITY™ (pilocarpine HCI Ophthalmic solution) 1.25%, the First and Only FDA-Approved Eye Drop to Treat Age-Related Blurry Near Vision (Presbyopia), is Now Available
by adminby adminHighlights – Presbyopia, or age-related blurry near vision, is a common, progressive condition that reduces the eye’s ability to focus on near…
-
AstraZenecaGlobal Market
AstraZeneca, Neurimmune Sign Exclusive Collaboration and License Agreement for NI006
by adminby adminSynopsis: Neurimmune AG, a biopharmaceutical company, announced that it has entered into an exclusive global collaboration and license agreement with Alexion, AstraZeneca’s…
-
AgrochemicalsGlobal MarketSanofi
Exscientia and Sanofi establish strategic Research collaboration to develop AI-Driven Pipeline of Precision-Engineered Medicines
by adminby adminHighlights : Collaborative efforts aim to accelerate drug discovery and improve clinical success Agreement to utilize Exscientia’s AI-based capabilities and personalised medicine…
-
CompaniesGlobal MarketNovartis
Novartis announces U.S. Court of Appeals for the Federal Circuit (CAFC) upholds validity of Gilenya® (fingolimod) dosage regimen patent.
by adminby adminSynopsis: -Novartis announced that the U.S. Court of Appeals for the Federal Circuit (CAFC) issued its decision upholding the validity of US…
-
Biocon PharmaceuticalCompanies
US Court Gives Favourable Order to Viatris Over Sanofi
by adminby adminSummary : -Biocon Biologics Ltd, said its partner Viatris has won favourable decisions from a US federal court in Sanofi’s challenge over…
-
CompaniesMolnupiravirSun Pharma
Sun Pharma arm receives DCGI approval for Molnupiravir in India
by adminby adminSynopsis : – Sun Pharmaceutical Industries Limited announced that one of its wholly owned subsidiaries has received Emergency Use Authorization (EUA) from…
-
AgrochemicalsCompaniesGlobal MarketPharma Science & Research
Takeda’s Eohilia Suffers Another Set Back FDA rejection after Mysterious Delay
by adminby adminSynopsis: -The FDA recommended Takeda run an additional clinical study to resolve its questions around Eohilia, an oral suspension formulation of the…
-
CompaniesNovartisRegulatoryU.S FDA
Novartis Cosentyx® Receives FDA Approval for the Treatment of Children and Adolescents with Enthesitis-Related Arthritis and Psoriatic Arthritis
by adminby adminSummary : -New approvals are based on JUNIPERA trial data showing Cosentyx® (secukinumab) demonstrated reduced flare risk versus placebo and improvement in…
-
AgrochemicalsArgenx
Argenx Snags First US. FDA Approval With Vyvgart (efgartigimod alfa-fcab) win in Generalized Myasthenia Gravis
by adminby adminSynopsis: VYVGART is the first-and-only FDA-approved neonatal Fc receptor blocker 68% of anti-acetylcholine receptor (AChR) antibody positive gMG patients treated with VYVGART…